Fluvoxamine Maleate
23 NDCs across 8 manufacturers|23 Generic,0 Brand
Fluvoxamine Maleate is used to treat depressive disorder, obsessive-compulsive disorder and panic disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 5, 1994, and the first generic was approved Nov 29, 2000. FDA's Orange Book lists 28 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $23 million on Fluvoxamine Maleate across 428,000 claims for 58,000 beneficiaries.
Fluvoxamine Maleate is available as 23 NDCs from 8 manufacturers (23 generic, 0 brand), with NADAC prices from $0.15 to $4.08 per EA — the most expensive product costs about 27× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
23G / 0B
Manufacturers
8
competing in market
Price Spread
$0.15 – $4.08
per EA
7d Activity
avg -3.8% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bionpharma Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin Reuptake Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing FLUVOXAMINE MALEATE
Frequently Asked Questions
What is Fluvoxamine Maleate used to treat?
Fluvoxamine Maleate is used to treat depressive disorder, obsessive-compulsive disorder and panic disorder, per the National Library of Medicine's MED-RT classification.
When did Fluvoxamine Maleate become available as a generic?
FDA approved the first generic Fluvoxamine Maleate (ANDA) on Nov 29, 2000. The Orange Book currently lists 28 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Fluvoxamine Maleate?
In 2024, Medicare Part D spent $23 million on Fluvoxamine Maleate across 428,000 claims for 58,000 beneficiaries.
How many Fluvoxamine Maleate products are on the market?
The Fluvoxamine Maleate drug market contains 23 NDCs from 8 manufacturers — 23 generic and 0 brand products.
What is the price range for Fluvoxamine Maleate?
NADAC reference prices for Fluvoxamine Maleate range from $0.1514 to $4.0776 per EA — the most expensive product costs about 27× the cheapest.
Which manufacturers make Fluvoxamine Maleate?
8 manufacturers list Fluvoxamine Maleate in NADAC. Ranked by number of NDCs, the largest are Bionpharma Inc. (6), Chartwell RX LLC (3), Apotex Corp. (3), ANI Pharmaceuticals, Inc. (3), Actavis Pharma, Inc. (2).
How has the price of Fluvoxamine Maleate changed recently?
Over the past 7 days, 4 Fluvoxamine Maleate NDCs rose and 17 fell, with a market-wide average change of -3.8%.